Photo of Anna Moeller
D Illinois House · District 43 On the 2026 ballot

Rep. Anna Moeller

Compare
Total votes
11,479
all sessions
Attendance
97%
355 missed
Higher than 84% of chamber peers
With party
97%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
1,182
bills & resolutions
Near the chamber average
Committees
5
assignments
1,182 bills and resolutions

Sponsored bills

Total
1,182
Primary
225
Co-sponsor
957
This page
1,182
matching current filters
Co-sponsor HB 342
Signed into law · Illinois House · Co-sponsor
EDUCATION-TECH

Amends the School Code. Makes a technical change in a Section concerning the School Code's construction.

Signed into law Aug 3, 2023 1 co-sponsor
Co-sponsor SB 1072
Signed into law · Illinois Senate · Co-sponsor
GOVERNMENT-TECH

Amends the State Employees Group Insurance Act of 1971. Makes a technical change in a Section concerning the short title.

Signed into law Jul 31, 2023 1 co-sponsor
Co-sponsor HB 1615
Signed into law · Illinois House · Co-sponsor
NURSE WORKFORCE CENTER-SURVEYS

Amends the Nurse Practice Act. Provides legislative findings. Provides that a primary goal of the Illinois Nursing Workforce Center is to develop a strategic plan for nursing workforce in the State by selecting priorities to be addressed, including: (1) for license renewals beginning in 2024 and each renewal thereafter, to develop and require the completion of a supply survey of all licensed nurses at initial licensure and each license renewal thereafter; and (2) no later than 2026, to develop a nurse demand and employer survey to be collected biennially.

Signed into law Jul 28, 2023 1 co-sponsor
Co-sponsor HB 2123
Signed into law · Illinois House · Co-sponsor
DIGITAL FORGERIES ACT

Creates the Digital Forgeries Act. Provides that an individual depicted in a digital forgery has a cause of action against any person who, without the consent of the depicted individual, knowingly distributes a digital forgery, creates a digital forgery with intent to distribute, or solicits the creation of a digital forgery with the intent to distribute: (1) in order to harass, extort, threaten, or cause physical, emotional, reputational, or economic harm to an individual falsely depicted; (2) with reckless disregard for whether such a creation, distribution, reproduction, or manipulation will cause physical, emotional, reputational, or economic harm to an individual falsely depicted; or (3) in order to incite violence or interfere with an official proceeding. Allows a prevailing plaintiff to be awarded damages, costs, and additional relief. Allows the court to grant injunctive relief maintaining the confidentiality of a plaintiff using a pseudonym.

Signed into law Jul 28, 2023 1 co-sponsor
Co-sponsor HB 2392
Signed into law · Illinois House · Co-sponsor
SCH CD-LAST TEACHER EVALUATION

Amends the Evaluation of Certified Employees Article of the School Code. With respect to a school district's teacher evaluation plan, provides that a teacher does not need to undergo the last evaluation cycle before the teacher retires if the teacher has notified the school district of the teacher's intent to retire. Effective immediately.

Signed into law Jul 28, 2023 1 co-sponsor
Primary HB 3508
Signed into law · Illinois House · Lead sponsor
PFAS REDUCTION-FOREVER PATHWAY

Amends the PFAS Reduction Act. Provides that the amendatory Act may be referred to as the PFAS Pathways Act. Contains legislative findings. Requires the Environmental Protection Agency to: (1) require select wastewater treatment plants to report the results of analysis of raw influent sewage, treated sewage effluent, and sewage sludge residuals for PFAS; (2) produce and publish on the Agency's website a report on the eventual dispersion of PFAS through the treatment process; and (3) review the Agency's database of wastewater treatment plants, determine methods of processed sewage sludge disposal, and estimate the annual quantities of processed sewage sludge disposal on land, whether or not it is disposed of in-state or out-of-state. Requires the Prairie Research Institute's Illinois Sustainable Technology Center to: (1) review the list of contaminants of emerging concern in a specified report and determine what other chemical compounds have an environmental impact similar to PFAS; (2) determine appropriate methods for destroying PFAS; and (3) estimate the financial impact on wastewater treatment plants in this State from the methods for destroying PFAS. Allows the Agency to propose, and the Pollution Control Board to adopt, rules establishing maximum concentrations of PFAS that may be contained in an Exceptional Quality biosolid or sewage sludge that is to be applied to land. Makes a conforming change in the Environmental Protection Act.

Signed into law Jul 28, 2023 0 co-sponsors
Primary SB 67
Signed into law · Illinois Senate · Lead sponsor
NEWBORN METABOLIC SCREENING

Amends the Newborn Metabolic Screening Act. Requires the Department of Public Health to provide all newborns with screening tests for the presence of metachromatic leukodystrophy. Requires the testing to begin within 6 months following the occurrence of specified milestones. Allows the Department to require payment of an additional fee for the provision of metachromatic leukodystrophy screening tests. Contains other provisions.

Signed into law Jul 28, 2023 0 co-sponsors
Co-sponsor HB 3370
Signed into law · Illinois House · Co-sponsor
PREVAILING WAGE-POWER WASHING

Amends the Prevailing Wage Act. Provides that the definition of "public works" includes power washing projects in which steam or pressurized water, with or without added abrasives or chemicals, is used to remove paint or other coatings, oils or grease, corrosion, or debris from a surface or to prepare a surface for a coating.

Signed into law Jul 28, 2023 1 co-sponsor
Co-sponsor HB 3819
Signed into law · Illinois House · Co-sponsor
LOCAL DEFLECTION PROGRAMS

Amends the Community-Law Enforcement and Other First Responder Partnership for Deflection and Substance Use Disorder Treatment Act. Changes the Act name to the Community Partnership for Deflection and Substance Use Disorder Treatment Act. Modifies and adds definitions. Provides that A law enforcement agency, other first responder entity, or local government agency (rather than only a law enforcement agency or other first responder entity) may establish a deflection program in partnership with one or more licensed providers of substance use disorder treatment services and one or more community members or organizations. Provides that a deflection program may involve a pre-arrest diversion response and proactive identification of persons thought likely to have an untreated or undiagnosed mental illness. Provides that a local deflection program shall also include case management and restorative justice aspects. Provides that a deflection program may accept, receive, and disburse, in furtherance of its duties and functions, any funds, grants, and services made available by the State and its agencies, the federal government and its agencies, units of local government, and private or civic sources. Provides that activities eligible for funding under the Act include naloxone and related harm reduction supplies (rather than related supplies) necessary for carrying out overdose prevention and reversal (rather than overdose reversal) for purposes of distribution to program participants or for use by law enforcement, other first responders, or local governmental agencies and wraparound participant funds to be used to incentivize participation and meet participant needs. Provides that the Legislative Reference Bureau shall reassign the Act in the Illinois Compiled Statutes (to reflect the addition of local government agencies to the Act).

Signed into law Jul 28, 2023 1 co-sponsor
Co-sponsor HB 3957
Signed into law · Illinois House · Co-sponsor
GENERIC DRUG PRICING FAIRNESS

Creates the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act. Provides that a manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug. Provides that the Director of Healthcare and Family Services or Director of Central Management Services may notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the State’s Medical Assistance Program or a State health plan, respectively, that amounts to price gouging. Provides that whenever the Attorney General has reason to believe that a manufacturer or wholesale drug distributor of an essential off-patent or generic drug has violated the Act, the Attorney General shall send a notice to the manufacturer or wholesale drug distributor requesting a specified statement. Provides that within 45 days after receipt of the request, the manufacturer or wholesale drug distributor shall submit the statement to the Attorney General. Provides that to accomplish the objectives and carry out the duties prescribed in the Act, the Attorney General may issue subpoenas or examine under oath any person to determine whether a manufacturer or wholesale drug distributor has violated the Act. Provides that upon petition of the Attorney General, a circuit court may issue specified orders against violations of the Act. Contains provisions concerning the disclosure of financial information provided by a manufacturer or wholesale drug distributor to the Attorney General. Effective January 1, 2024.

Signed into law Jul 28, 2023 1 co-sponsor
Showing 461 to 470 of 1,182 bills
Previous 1 … 46 47 48 … 119 Next